Fasenra 30 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XPA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $7,331
Award facts
- Contract value 100% obligated
- $7,330.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,330.50 on July 22, 2025, for the supply of Fasenra 30 mg/ml syringes. The contract, with an ultimate completion date of July 23, 2025, was issued without a set-aside designation and funded by the Defense Logistics Agency's Medical Supply Chain division. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables for military healthcare facilities.
As a critical supplier within the federal pharmaceutical supply chain since its registration in SAM.gov in 2001, DMS Pharmaceutical Group maintains a robust portfolio of federal contract awards covering branded and generic prescription drugs, biologics, and specialized medical products. The Fasenra delivery represents the company's continued provision of high-value pharmaceutical solutions to the Department of Defense healthcare system, supporting medical supply needs of military health facilities. The company's woman-owned small business status and established distribution capabilities position it as a key vendor for fulfilling the Defense Logistics Agency's pharmaceutical procurement requirements across the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DX25F6XPA?
SPE2DX25F6XPA was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 22, 2025.
How much is contract SPE2DX25F6XPA worth?
The government has obligated $7,331 on SPE2DX25F6XPA.
Is contract SPE2DX25F6XPA an order under another contract?
Yes. SPE2DX25F6XPA is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XPA competed?
The extent of competition for SPE2DX25F6XPA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award